Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sjögren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine / Ferraccioli, Gf; Salaffi, Fausto; De Vita, S; Casatta, L; Avellini, C; Carotti, M; Beltrami, Ca; Cervini, C; Bartoli, E.. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 14 (4):(1996), pp. 367-371.
Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sjögren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine
SALAFFI, FAUSTO;Carotti M;
1996-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
